Clinical Trial Update: CellFX ® Percutaneous Electrode (PE) Treatment of Symptomatic Benign Thyroid Nodules [NA]

View source ↗

Summary

Pulse Biosciences announced that its CellFX Percutaneous Electrode treatment for symptomatic benign thyroid nodules has completed its clinical trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Thyroid Nodules

Drugs mentioned

• CellFX Percutaneous Electrode

Snippet

Sponsor: Pulse Biosciences, Inc. | Conditions: Thyroid Nodule (Benign) | NA | Status: COMPLETED